APPLICATION
ANDA206430
TYPE
ANDA
ORIGINAL APPROVAL
2019-04-19
LATEST ACTION
2019-04-19
ROUTE
INTRAVESICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
VALRUBICINPrescription
VALRUBICIN 40MG/ML · SOLUTION · INTRAVESICAL
Approval history
2019-04-19UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.